![Qing Ling Yu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Qing Ling Yu
Chief Executive Officer at Beijing Advaccine Biotechnology Co., Ltd.
Qing Ling Yu active positions
Companies | Position | Start | End |
---|---|---|---|
Beijing Advaccine Biotechnology Co., Ltd.
![]() Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | Director/Board Member | 2009-04-07 | - |
Chief Executive Officer | 2009-04-07 | - | |
President | 2009-04-07 | - |
Career history of Qing Ling Yu
Training of Qing Ling Yu
University of International Business & Economics | Undergraduate Degree |
Statistics
International
China | 3 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
![]() | Health Technology |
- Stock Market
- Insiders
- Qing Ling Yu
- Experience